-
Symbol
-
EIKN on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
4,148,519 shares
-
Security Ownership %
-
7.7%
James B. Tananbaum ownership in Eikon Therapeutics, Inc. Common Stock, par value $0.0001 per share (EIKN)
11 Feb 2026 - James B. Tananbaum has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,148,519 shares of Eikon Therapeutics, Inc. Common Stock, par value $0.0001 per share (EIKN).
This represents 7.7% ownership of the company.
This is the first filing by Foresite Capital Fund IV, L.P. disclosing ownership of Eikon Therapeutics, Inc. Common Stock, par value $0.0001 per share (EIKN).